Meta-analysis of the association between miR-196a-2 polymorphism and cancer susceptibility

Cancer Biology and Medicine

Volumn 9, Issue 1, 2012, Pages 63-72

  Zhang, Huan ^a   Su, Yu Liang ^a   Yu, Herbert ^b   Qian, Bi Yun ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF HAWAII CANCER CENTER   (United States)

Author keywords

Human; Meta analysis; MIRN196 microRNA; Neoplasms; Polymorphism

Indexed keywords

MICRORNA; MICRORNA 196A 2; UNCLASSIFIED DRUG;

ALLELE; ARTICLE; ASIAN; BREAST CANCER; CANCER RISK; CANCER SUSCEPTIBILITY; CARCINOGENESIS; CASE CONTROL STUDY; COLORECTAL CANCER; CONTROLLED STUDY; DNA SEQUENCE; ESOPHAGUS CANCER; ETHNIC GROUP; ETHNICITY; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC MODEL; GENETIC POLYMORPHISM; GENOTYPE; GENOTYPE ENVIRONMENT INTERACTION; HIGH RESOLUTION MELTING ANALYSIS; HUMAN; LIVER CANCER; LUNG CANCER; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; STOMACH CANCER;

EID: 84870619513     PISSN: 20953941     EISSN: None     Source Type: Journal    
DOI: 10.3969/j.issn.2095-3941.2012.01.012     Document Type: Article

References (49)

1. Siegel R, Naishadham D, Jemal A: Cancer statistics, 2012. CA Cancer J Clin 2012; 62: 10-29 (Epub 2012 Jan 4).
2. Lichtenstein P, Holm NV, Verkasalo PK, et al. Environmental and heritable factors in the causation of cancer--analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med 2000; 343: 78-85.
3. Lagos-Quintana M, Rauhut R, Lendeckel W, et al. Identification of novel genes coding for small expressed RNAs. Science 2001; 294: 853-858.
4. Bartel DP. MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell 2004; 116: 281-297.
5. Bertino JR, Banerjee D, Mishra PJ. Pharmacogenomics of microRNA: A miRSNP towards individualized therapy. Pharmacogenomics 2007; 8: 1625-1627.
6. Lewis BP, Burge CB, Bartel DP. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 2005; 120: 15-20.
7. Chen JF, Mandel EM, Thomson JM, et al. The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation. Nat Genet 2006; 38: 228-233.
8. Gregory RI, Shiekhattar R. MicroRNA biogenesis and cancer. Cancer Res 2005; 65: 3509-3512.
9. Esquela-Kerscher A, Slack FJ. Oncomirs-microRNAs with a role in cancer. Nat Rev Cancer 2006; 6: 259-269.
10. Duan R, Pak C, Jin P. Single nucleotide polymorphism associated with mature miR-125a alters the processing of pri-miRNA. Hum Mol Genet 2007; 16: 1124-1131.
11. Han J, Lee Y, Yeom KH, et al. Molecular basis for the recognition of primary microRNAs by the Drosha-DGCR8 complex. Cell 2006; 125: 887-901.
12. Horikawa Y, Wood CG, Yang H, et al. Single nucleotide polymorphisms of microRNA machinery genes modify the risk of renal cell carcinoma. Clin Cancer Res 2008; 14: 7956-7962.
13. Hu Z, Chen J, Tian T, et al. Genetic variants of miRNA sequences and non-small cell lung cancer survival. J Clin Invest 2008; 118: 2600-2608.
14. Hong YS, Kang HJ, Kwak JY, et al. Association between microRNA196a2 rs11614913 genotypes and the risk of non-small cell lung cancer in Korean population. J Prev Med Public Health; 44: 125-130.
15. Tian T, Shu Y, Chen J, et al. A functional genetic variant in microRNA-196a2 is associated with increased susceptibility of lung cancer in Chinese. Cancer Epidemiol Biomarkers Prev 2009; 18: 1183-1187.
16. Hoffman AE, Zheng T, Yi C, et al. microRNA miR-196a-2 and breast cancer: A genetic and epigenetic association study and functional analysis. Cancer Res 2009, 69: 5970-5977.
17. Dou T, Wu Q, Chen X, et al. A polymorphism of microRNA196a genome region was associated with decreased risk of glioma in Chinese population. J Cancer Res Clin Oncol 2010; 136: 1853-1859.
18. Peng S, Kuang Z, Sheng C, et al. Association of microRNA-196a-2 gene polymorphism with gastric cancer risk in a Chinese population. Dig Dis Sci 2010; 55: 2288-2293.
19. Srivastava K, Srivastava A, Mittal B. Common genetic variants in pre-microRNAs and risk of gallbladder cancer in North Indian population. J Hum Genet 2010; 55: 495-499.
20. Liu Z, Li G, Wei S, et al. Genetic variants in selected premicroRNA genes and the risk of squamous cell carcinoma of the head and neck. Cancer 2010; 116: 4753-4760.
21. Ye Y, Wang KK, Gu J, et al. Genetic variations in microRNArelated genes are novel susceptibility loci for esophageal cancer risk. Cancer Prev Res (Phila) 2008; 1: 460-469.
22. Li XD, Li ZG, Song XX, et al. A variant in microRNA-196a2 is associated with susceptibility to hepatocellular carcinoma in Chinese patients with cirrhosis. Pathology 2010; 42: 669-673.
23. Akkiz H, Bayram S, Bekar A, et al. A functional polymorphism in pre-microRNA-196a-2 contributes to the susceptibility of hepatocellular carcinoma in a Turkish population: A case-control study. J Viral Hepat, 2011; 18: e399-407.
24. Min KT, Kim JW, Jeon YJ, et al. Association of the miR-146aC>G, 149C>T, 196a2C>T, and 499A>G polymorphisms with colorectal cancer in the Korean population. Mol Carcinog (Epub ahead of print).
25. Zhang M, Jin M, Yu Y, et al. Associations of miRNA polymorphisms and female physiological characteristics with breast cancer risk in Chinese population. Eur J Cancer Care (Engl) 2012; 21: 274-80 (Epub 2011 Nov 11).
26. Zhan JF, Chen LH, Chen ZX, et al. A functional variant in microRNA-196a2 is associated with susceptibility of colorectal cancer in a Chinese population. Arch Med Res 2011; 42: 144-148.
27. Zhou B, Wang K, Wang Y, et al. Common genetic polymorphisms in pre-microRNAs and risk of cervical squamous cell carcinoma. Mol Carcinog, 2011; 50: 499-505.
28. Zhang XW, Pan SD, Feng YL, et al. Relationship between genetic polymorphism in microRNAs precursor and genetic predisposition of hepatocellular carcinoma. Zhonghua Yu Fang Yi Xue Za Zhi 45: 239-243.
29. Zhu L, Chu H, Gu D, et al. A Functional Polymorphism in miRNA-196a2 Is Associated with Colorectal Cancer Risk in a Chinese Population. DNA Cell Biol 2012; 31: 349-353 (Epub 2011 Aug 4).
30. Chen H, Sun LY, Chen LL, et al. A variant in microRNA-196a2 is not associated with susceptibility to and progression of colorectal cancer in Chinese. Intern Med J 2012; 42: e115-119.
31. Okubo M, Tahara T, Shibata T, et al. Association between common genetic variants in pre-microRNAs and gastric cancer risk in Japanese population Helicobacter 2010; 15: 524-531.
32. Wang K, Guo H, Hu H, et al. A functional variation in premicroRNA196a is associated with susceptibility of esophageal squamous cell carcinoma risk in Chinese Han. Biomarkers, 2010; 15: 614-618.
33. Qi P, Dou TH, Geng L, et al. Association of a variant in MIR 196A2 with susceptibility to hepatocellular carcinoma in male Chinese patients with chronic hepatitis B virus infection. Hum Immunol 2010; 71: 621-626.
34. Hu Z, Liang J, Wang Z, et al. Common genetic variants in premicroRNAs were associated with increased risk of breast cancer in Chinese women. Hum Mutat 2009; 30: 79-84.
35. Kim MJ, Yoo SS, Choi YY, et al. A functional polymorphism in the pre-microRNA-196a2 and the risk of lung cancer in a Korean population. Lung Cancer 2010; 69: 127-129.
36. Jedlinski DJ, Gabrovska PN, Weinstein SR, et al. Single nucleotide polymorphism in hsa-mir-196a-2 and breast cancer risk: A case control study. Twin Res Hum Genet 2011; 14: 417-421.
37. Mittal RD, Gangwar R, George GP, et al. Investigative role of premicroRNAs in bladder cancer patients: A case-control study in North India. DNA Cell Biol, 2011; 30: 401-406.
38. George GP, Gangwar R, Mandal RK, et al. Genetic variation in microRNA genes and prostate cancer risk in North Indian population. Mol Biol Rep 2011; 38: 1609-1615.
39. Catucci I, Yang R, Verderio P, et al. Evaluation of SNPs in miR146a, miR196a2 and miR-499 as low-penetrance alleles in German and Italian familial breast cancer cases. Hum Mutat 2010; 31: E1052-1057.
40. Vinci S, Gelmini S, Pratesi N, et al. Genetic variants in miR-146a, miR-149, miR-196a2, miR-499 and their influence on relative expression in lung cancers. Clin Chem Lab Med 2011; 49: 2073-2080.
41. Higgins JP, Thompson SG. Quantifying heterogeneity in a metaanalysis. Stat Med 2002; 21: 1539-1558.
42. Huedo-Medina TB, Sanchez-Meca J, Marin-Martinez F, et al. Assessing heterogeneity in meta-analysis: Q statistic or I2 index? Psychol Methods 2006; 11: 193-206.
43. Lau J, Ioannidis JP, Schmid CH. Quantitative synthesis in systematic reviews. Ann Intern Med 1997; 127: 820-826.
44. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 1959; 22: 719-748.
45. Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994; 50: 1088-1101.
46. Egger M, Davey Smith G, Schneider M, et al. Bias in metaanalysis detected by a simple, graphical test. BMJ 1997; 315: 629-634.
47. Saunders MA, Liang H, Li WH. Human polymorphism at microRNAs and microRNA target sites. Proc Natl Acad Sci USA 2007; 104: 3300-3305.
48. Chu H, Wang M, Shi D, et al. Hsa-miR-196a2 Rs11614913 polymorphism contributes to cancer susceptibility: evidence from 15 case-control studies. PLoS One 2011; 6: e18108.
49. Guo J, Jin M, Zhang M, et al. A Genetic Variant in miR-196a2 Increased Digestive System Cancer Risks: A Meta-Analysis of 15 Case-Control Studies. PLoS One 2012; 7: e30585.